IV 
115TH CONGRESS 
2D SESSION 
H. RES. 812 
Supporting quality of life for prostate cancer patients. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 10, 2018 
Mr. PAULSEN (for himself and Mr. PAYNE) submitted the following resolution; 
which was referred to the Committee on Energy and Commerce, and in 
addition to the Committees on Ways and Means, and Veterans’ Affairs, 
for a period to be subsequently determined by the Speaker, in each case 
for consideration of such provisions as fall within the jurisdiction of the 
committee concerned 
RESOLUTION 
Supporting quality of life for prostate cancer patients. 
Whereas an estimated 164,690 men will be diagnosed with 
prostate cancer in 2018 adding to the estimated more 
than 2,900,000 men currently living with prostate cancer 
in the United States; 
Whereas approximately 15 percent of men will be diagnosed 
with prostate cancer during their lifetime and prostate 
cancer is the second leading cause of death in men in the 
United States; 
Whereas African-American males suffer from a 60-percent 
higher incidence of prostate cancer than White males and 
have an almost 250-percent higher mortality rate than 
White males; 
VerDate Sep 11 2014 
02:14 Apr 11, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR812.IH
HR812
lotter on DSKBCFDHB2PROD with BILLS
•HRES 812 IH 
Whereas certain veterans populations may have nearly twice 
the incidence of prostate cancer as the general population 
of the United States; 
Whereas there are a number of options available to men to 
treat prostate cancer, including radiation, hormone ther-
apy, chemotherapy, and a radical prostatectomy; 
Whereas many men who undertake these treatment options 
for their prostate cancer will experience significant side 
effects including incontinence and impotence; 
Whereas the side effects of prostate treatment can negatively 
affect a prostate cancer survivor’s quality of life and con-
tribute to depression and anxiety; 
Whereas the spouse or partner of the prostate cancer survivor 
is emotionally impacted as the intimacy of the relation-
ship can become strained; 
Whereas prostate cancer survivors suffering from the side ef-
fects of treatment deserve access to the prosthetic uro-
logic interventions and reconstructive surgeries that can 
restore the patient to a physical state similar to that 
prior to the prostate cancer treatment; 
Whereas the need for these urologic restoration products can 
also be a last line of intervention for patients suffering 
from diabetes, cardiovascular disease, Parkinson’s dis-
ease, or multiple sclerosis; and 
Whereas Medicare and the Veterans’ Administration cur-
rently cover medical devices such as artificial urinary 
sphincters and penile prosthesis: Now, therefore, be it 
Resolved, That it is the sense of the House of Rep-
resentatives that Congress should protect Medicare or Vet-
erans’ Administration benefits for medical device treat-
VerDate Sep 11 2014 
02:14 Apr 11, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HR812.IH
HR812
lotter on DSKBCFDHB2PROD with BILLS
•HRES 812 IH 
ments for male incontinence and impotence that result 
from treatment for prostate cancer, diabetes, cardio-
vascular disease, Parkinson’s disease, or multiple sclerosis 
and that any such coverage decisions should be based on 
data and made after careful review by medical experts 
with a critical eye toward the impact of coverage decisions 
on the Medicare and Veterans’ Administration popu-
lations. 
Æ 
VerDate Sep 11 2014 
02:14 Apr 11, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR812.IH
HR812
lotter on DSKBCFDHB2PROD with BILLS